Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.
- DOI
- 10.1200/jco.2008.19.9331
- Published
- 2009-04-20
- Container
- J Clin Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco.2008.19.9331,
title = {Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.},
author = {Karp DD and Paz-Ares LG and Novello S and Haluska P and Garland L and Cardenal F and Blakely LJ and Eisenberg PD and Langer CJ and Blumenschein G and Johnson FM and Green S and Gualberto A.},
year = {2009},
journal = {J Clin Oncol},
doi = {10.1200/jco.2008.19.9331},
url = {https://doi.org/10.1200/jco.2008.19.9331}
}RIS
TY - JOUR TI - Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. AU - Karp DD AU - Paz-Ares LG AU - Novello S AU - Haluska P AU - Garland L AU - Cardenal F AU - Blakely LJ AU - Eisenberg PD AU - Langer CJ AU - Blumenschein G AU - Johnson FM AU - Green S AU - Gualberto A. PY - 2009 JO - J Clin Oncol DO - 10.1200/jco.2008.19.9331 UR - https://doi.org/10.1200/jco.2008.19.9331 ER -
APA
DD, K., LG, P., S, N., P, H., L, G., F, C., LJ, B., PD, E., CJ, L., G, B., FM, J., S, G., & A., G. (2009). Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.. J Clin Oncol. https://doi.org/10.1200/jco.2008.19.9331
Source records
- europe-pmc · retrieved 2026-09-24T23:10:59.734Z